AryoGen’s research project titled “Production of Monoclonal Antibody Denosumab to Treat Osteoporosis, Bone Cancer, and Hypercalcemia” was chosen as one of the top ten from among 3200 knowledge base, novel, and technological projects, innovations, and products in Rab’e Rashidi Innovation and Technology Exhibition (Rinotex 2019)